PURIXAN

PURIXAN was reported 779 times

PURIXAN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ANTITHROMBIN III 1 0.0625
1 WALLED-OFF PANCREATIC NECROSIS 1 0.0556
2 RECTOVAGINAL SEPTUM ABSCESS 1 0.0455
3 KNUCKLE PADS 1 0.0435
4 DRUG METABOLITE LEVEL HIGH 3 0.0357
5 ANGIOLYMPHOID HYPERPLASIA WITH EOSINOPHILIA 1 0.0294
6 CENTRAL HYPOTHYROIDISM 9 0.0272
7 MULTIPLE LENTIGINES SYNDROME 1 0.0263
8 PERINEAL NECROSIS 1 0.0244
9 GASTROINTESTINAL DILATION PROCEDURE 1 0.0213
10 PROSTATITIS ESCHERICHIA COLI 1 0.0200
11 JUVENILE CHRONIC MYELOMONOCYTIC LEUKAEMIA 1 0.0196
12 VIRAL TONSILLITIS 1 0.0179
13 COAGULATION FACTOR VII LEVEL DECREASED 2 0.0179
14 GENETIC POLYMORPHISM 1 0.0175
15 MYELODYSPLASTIC SYNDROME TRANSFORMATION 9 0.0173
16 HEPATIC CANDIDIASIS 1 0.0147
17 HISTIOCYTIC SARCOMA 1 0.0128
18 GASTROENTERITIS ASTROVIRAL 1 0.0125
19 BLASTIC PLASMACYTOID DENDRITIC CELL NEOPLASIA 1 0.0123
20 PORTAL SHUNT 1 0.0123
21 ADRENOCORTICAL CARCINOMA 1 0.0114
22 ANTITHROMBIN III DEFICIENCY 1 0.0112
23 MUCOCUTANEOUS CANDIDIASIS 1 0.0108
24 PULMONARY HISTOPLASMOSIS 1 0.0100
25 OVERGROWTH FUNGAL 1 0.0097
26 ACQUIRED FACTOR V DEFICIENCY 1 0.0091
27 BILIRUBIN CONJUGATED ABNORMAL 1 0.0090
28 FISTULA INFLAMMATION 1 0.0081
29 VIRAL SKIN INFECTION 1 0.0081
30 FEBRILE BONE MARROW APLASIA 32 0.0075
31 RELAPSING FEVER 2 0.0069
32 PLACENTAL TRANSFUSION SYNDROME 1 0.0069
33 GALLBLADDER OEDEMA 2 0.0068
34 ALLERGIC TRANSFUSION REACTION 1 0.0066
35 MYCOPLASMA TEST POSITIVE 1 0.0066
36 SECONDARY HYPOTHYROIDISM 1 0.0065
37 GASTROENTERITIS ROTAVIRUS 2 0.0065
38 COAGULATION FACTOR V LEVEL DECREASED 2 0.0061
39 LENTIGO 3 0.0060
40 ENTEROVIRUS TEST POSITIVE 1 0.0057
41 HERPES ZOSTER MENINGOENCEPHALITIS 2 0.0056
42 INFLUENZA B VIRUS TEST POSITIVE 1 0.0055
43 ACUTE MONOCYTIC LEUKAEMIA 1 0.0055
44 CUTANEOUS MUCORMYCOSIS 1 0.0054
45 HIGH-GRADE B-CELL LYMPHOMA 1 0.0053
46 PERINEAL INFECTION 1 0.0051
47 NEUTROPHIL COUNT 1 0.0048
48 CHOLESTASIS OF PREGNANCY 2 0.0043
49 NECROTISING SOFT TISSUE INFECTION 1 0.0043
50 MUCOSAL INFECTION 1 0.0043
51 SWEAT GLAND TUMOUR 1 0.0043
52 SPONTANEOUS BACTERIAL PERITONITIS 1 0.0041
53 EPSTEIN BARR VIRUS POSITIVE MUCOCUTANEOUS ULCER 2 0.0041
54 CUTANEOUS LEISHMANIASIS 1 0.0040
55 ERYTHEMA INFECTIOSUM 1 0.0039
56 OEDEMATOUS KIDNEY 1 0.0038
57 CHOLANGITIS INFECTIVE 1 0.0038
58 MEASLES 2 0.0037
59 CHRONIC HEPATITIS 3 0.0037
60 ANTITHROMBIN III DECREASED 1 0.0037
61 INTESTINAL DIAPHRAGM DISEASE 1 0.0036
62 BILE ACID MALABSORPTION 1 0.0035
63 DILATATION INTRAHEPATIC DUCT ACQUIRED 1 0.0034
64 ALOPECIA UNIVERSALIS 1 0.0034
65 CYTOMEGALOVIRUS GASTROINTESTINAL INFECTION 1 0.0034
66 HISTOPLASMOSIS DISSEMINATED 5 0.0031
67 NODULAR REGENERATIVE HYPERPLASIA 2 0.0031
68 INTESTINAL ANASTOMOSIS 2 0.0031
69 VULVITIS 1 0.0030
70 ILEOCAECAL RESECTION 1 0.0029
71 RHINOCEREBRAL MUCORMYCOSIS 1 0.0029
72 ANASTOMOTIC LEAK 2 0.0029
73 GASTROINTESTINAL MICROORGANISM OVERGROWTH 1 0.0028
74 CYTOMEGALOVIRUS HEPATITIS 1 0.0028
75 PSEUDOPOLYP 1 0.0028
76 SPLENIC LESION 1 0.0027
77 HEPATOSPLENIC T-CELL LYMPHOMA 1 0.0027
78 HUMAN RHINOVIRUS TEST POSITIVE 1 0.0027
79 PENILE ERYTHEMA 1 0.0027
80 VIRAL MYOCARDITIS 1 0.0027
81 PARVOVIRUS INFECTION 1 0.0025
82 ATYPICAL HAEMOLYTIC URAEMIC SYNDROME 2 0.0025
83 BLOOD PRODUCT TRANSFUSION DEPENDENT 1 0.0024
84 METASTASES TO PANCREAS 1 0.0023
85 ANAEMIA MEGALOBLASTIC 1 0.0022
86 PNEUMATOSIS 1 0.0022
87 MANUFACTURING ISSUE 1 0.0022
88 CENTRAL VENOUS CATHETER REMOVAL 1 0.0021
89 MECHANICAL URTICARIA 1 0.0021
90 MINIMAL RESIDUAL DISEASE 1 0.0021
91 ORAL CAVITY FISTULA 1 0.0020
92 HYPOFIBRINOGENAEMIA 2 0.0020
93 NEONATAL RESPIRATORY FAILURE 1 0.0020
94 SPLENIC HAEMORRHAGE 1 0.0020
95 HYPERLIPASAEMIA 1 0.0019
96 HEPATITIS E 3 0.0019
97 TRANSVERSE SINUS THROMBOSIS 1 0.0019
98 DRUG LEVEL ABNORMAL 1 0.0019
99 HYPERTRIGLYCERIDAEMIA 11 0.0019
100 HYPERTROPHY 1 0.0018
101 EPSTEIN-BARR VIRAEMIA 2 0.0018
102 KLEBSIELLA SEPSIS 2 0.0018
103 TRANSAMINASES ABNORMAL 1 0.0017
104 PSEUDOMONAL SEPSIS 3 0.0017
105 DOSE CALCULATION ERROR 1 0.0017
106 CEREBRAL ASPERGILLOSIS 1 0.0016
107 PROTHROMBIN TIME RATIO DECREASED 1 0.0016
108 ANAL INFLAMMATION 1 0.0016
109 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 4 0.0015
110 SMALL INTESTINE ULCER 1 0.0015
111 TRANSFORMATION TO ACUTE MYELOID LEUKAEMIA 1 0.0015
112 OESOPHAGITIS ULCERATIVE 1 0.0015
113 ARACHNOIDITIS 1 0.0014
114 PULMONARY VENO-OCCLUSIVE DISEASE 1 0.0014
115 RESPIRATORY SYNCYTIAL VIRUS TEST POSITIVE 1 0.0014
116 ACUTE LYMPHOCYTIC LEUKAEMIA 4 0.0014
117 PERINEAL PAIN 1 0.0014
118 INFECTION IN AN IMMUNOCOMPROMISED HOST 1 0.0014
119 PNEUMONIA PNEUMOCOCCAL 2 0.0013
120 GASTROINTESTINAL WALL THICKENING 2 0.0013
121 EXPOSURE TO COMMUNICABLE DISEASE 1 0.0013
122 TRACHEITIS 1 0.0013
123 COAGULATION TEST ABNORMAL 1 0.0013
124 PORTAL HYPERTENSION 4 0.0013
125 ACUTE FEBRILE NEUTROPHILIC DERMATOSIS 3 0.0013
126 PANCREATIC PSEUDOCYST 1 0.0013
127 BREAST FEEDING 1 0.0013
128 INTESTINAL ULCER 2 0.0013
129 SUPERIOR SAGITTAL SINUS THROMBOSIS 1 0.0013
130 RENAL ABSCESS 1 0.0012
131 HAND-FOOT-AND-MOUTH DISEASE 1 0.0012
132 ADRENAL MASS 1 0.0012
133 CAMPYLOBACTER INFECTION 1 0.0012
134 VENOOCCLUSIVE DISEASE 3 0.0012
135 PERITONSILLAR ABSCESS 1 0.0012
136 LUNG OPERATION 1 0.0012
137 POTENTIATING DRUG INTERACTION 4 0.0012
138 LEUKAEMIA RECURRENT 2 0.0012
139 PULMONARY CAVITATION 1 0.0011
140 HYPERAMMONAEMIC ENCEPHALOPATHY 2 0.0011
141 PAPILLARY THYROID CANCER 2 0.0011
142 JUGULAR VEIN THROMBOSIS 2 0.0011
143 MUCOSAL EROSION 1 0.0011
144 HEPATOTOXICITY 24 0.0011
145 BLOOD ALKALINE PHOSPHATASE DECREASED 1 0.0011
146 BICYTOPENIA 2 0.0010
147 STAPHYLOCOCCAL SEPSIS 5 0.0010
148 VENOOCCLUSIVE LIVER DISEASE 5 0.0010
149 MUCOSAL ULCERATION 1 0.0010
150 AUTISM 1 0.0010
151 ACUTE PROMYELOCYTIC LEUKAEMIA 1 0.0010
152 POST LUMBAR PUNCTURE SYNDROME 1 0.0010
153 CYTOGENETIC ANALYSIS ABNORMAL 1 0.0010
154 STAPHYLOCOCCUS TEST POSITIVE 2 0.0009
155 SMALL INTESTINAL STENOSIS 1 0.0009
156 KETOSIS 1 0.0009
157 OESOPHAGEAL VARICES HAEMORRHAGE 2 0.0009
158 PERIRECTAL ABSCESS 1 0.0009
159 NEOPLASM RECURRENCE 3 0.0009
160 PULMONARY GRANULOMA 1 0.0009
161 CORTISOL DECREASED 1 0.0009
162 PANCREATITIS NECROTISING 2 0.0009
163 CYTOMEGALOVIRUS COLITIS 2 0.0009
164 SYSTEMIC MYCOSIS 1 0.0009
165 PROCALCITONIN INCREASED 1 0.0009
166 ESCHERICHIA BACTERAEMIA 2 0.0008
167 PHYSICAL PRODUCT LABEL ISSUE 1 0.0008
168 BILE DUCT STENOSIS 1 0.0008
169 PHARYNGEAL INFLAMMATION 1 0.0008
170 MONOCYTE COUNT DECREASED 1 0.0008
171 OTITIS EXTERNA 1 0.0008
172 LARGE INTESTINE INFECTION 1 0.0008
173 HEPATIC INFECTION 1 0.0008
174 ILEOSTOMY 2 0.0008
175 BLOOD BILIRUBIN ABNORMAL 1 0.0008
176 RHINOVIRUS INFECTION 3 0.0008
177 APLASTIC ANAEMIA 4 0.0008
178 GASTROENTERITIS NOROVIRUS 1 0.0008
179 LIP EXFOLIATION 1 0.0008
180 CHEILITIS 4 0.0007
181 STENOTROPHOMONAS INFECTION 1 0.0007
182 SIALOADENITIS 1 0.0007
183 URETERIC OBSTRUCTION 1 0.0007
184 EFFUSION 1 0.0007
185 MENINGITIS VIRAL 1 0.0007
186 CHOLECYSTITIS INFECTIVE 2 0.0007
187 PROCTITIS 2 0.0007
188 PROTHROMBIN TIME SHORTENED 1 0.0007
189 ACUTE GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0007
190 HEPATOCELLULAR INJURY 10 0.0007
191 BLOOD ELECTROLYTES DECREASED 1 0.0007
192 NEUTROPENIC SEPSIS 5 0.0007
193 BLADDER TRANSITIONAL CELL CARCINOMA 1 0.0007
194 PRODUCT MONITORING ERROR 1 0.0007
195 ESCHERICHIA SEPSIS 2 0.0007
196 ADENOVIRUS INFECTION 2 0.0007
197 BONE MARROW FAILURE 14 0.0007
198 PANCREATIC ENZYMES INCREASED 1 0.0007
199 ACUTE ABDOMEN 1 0.0007
200 NORMOCYTIC ANAEMIA 1 0.0007
201 BILIARY DILATATION 1 0.0007
202 CHOLESTASIS 13 0.0007
203 HYPERBILIRUBINAEMIA 7 0.0007
204 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
205 PELVIC INFLAMMATORY DISEASE 1 0.0007
206 BONE MARROW DISORDER 2 0.0007
207 ASPARTATE AMINOTRANSFERASE ABNORMAL 1 0.0007
208 HYPOALBUMINAEMIA 5 0.0006
209 PRODUCT DEPOSIT 1 0.0006
210 EPSTEIN-BARR VIRUS INFECTION 4 0.0006
211 ONYCHOLYSIS 1 0.0006
212 MEGACOLON 1 0.0006
213 PNEUMONIA VIRAL 2 0.0006
214 RECTAL ABSCESS 1 0.0006
215 FEMALE GENITAL TRACT FISTULA 1 0.0006
216 HEPATIC FIBROSIS 2 0.0006
217 RESPIRATORY SYNCYTIAL VIRUS INFECTION 5 0.0006
218 SPINAL CORD INJURY 1 0.0006
219 ALOPECIA AREATA 1 0.0006
220 LYMPHOPENIA 8 0.0006
221 HISTOPLASMOSIS 1 0.0006
222 DRUG MONITORING PROCEDURE NOT PERFORMED 1 0.0006
223 ANAL ABSCESS 3 0.0006
224 CUTANEOUS VASCULITIS 2 0.0005
225 BODY TEMPERATURE ABNORMAL 1 0.0005
226 CEREBROSPINAL FLUID LEAKAGE 1 0.0005
227 DIFFUSE ALOPECIA 1 0.0005
228 LYMPH NODE PAIN 1 0.0005
229 STENOSIS 1 0.0005
230 INTERVERTEBRAL DISCITIS 1 0.0005
231 HYPOGLYCAEMIA 25 0.0005
232 CAESAREAN SECTION 6 0.0005
233 PNEUMONIA CYTOMEGALOVIRAL 1 0.0005
234 APLASIA 1 0.0005
235 CELL DEATH 1 0.0005
236 LOW BIRTH WEIGHT BABY 4 0.0005
237 ANORECTAL DISORDER 1 0.0005
238 LARGE INTESTINAL STENOSIS 1 0.0005
239 DEVICE RELATED SEPSIS 1 0.0005
240 MUCOSAL INFLAMMATION 13 0.0005
241 NEUTROPHIL COUNT INCREASED 5 0.0005
242 RENAL MASS 1 0.0005
243 ATRIAL THROMBOSIS 1 0.0005
244 VARICELLA ZOSTER VIRUS INFECTION 1 0.0005
245 ALANINE AMINOTRANSFERASE ABNORMAL 1 0.0005
246 TORTICOLLIS 1 0.0005
247 FOETAL DISTRESS SYNDROME 1 0.0005
248 ESCHERICHIA URINARY TRACT INFECTION 2 0.0005
249 GRAFT VERSUS HOST DISEASE IN GASTROINTESTINAL TRACT 1 0.0005
250 OCULAR ICTERUS 2 0.0005
251 GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0005
252 DISEASE COMPLICATION 2 0.0004
253 BREAKTHROUGH PAIN 1 0.0004
254 HAEMOLYTIC URAEMIC SYNDROME 1 0.0004
255 PANCYTOPENIA 24 0.0004
256 RESPIRATORY TRACT INFECTION VIRAL 1 0.0004
257 DIARRHOEA HAEMORRHAGIC 4 0.0004
258 POLYOMAVIRUS-ASSOCIATED NEPHROPATHY 1 0.0004
259 CYTOMEGALOVIRUS INFECTION 7 0.0004
260 HAEMATOTOXICITY 4 0.0004
261 HAEMATOLOGICAL INFECTION 1 0.0004
262 BLOOD IMMUNOGLOBULIN G DECREASED 1 0.0004
263 HAEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS 3 0.0004
264 URINARY TRACT INFECTION BACTERIAL 1 0.0004
265 BRAIN ABSCESS 1 0.0004
266 POST TRANSPLANT LYMPHOPROLIFERATIVE DISORDER 2 0.0004
267 LIPASE INCREASED 3 0.0004
268 PRODUCT COLOUR ISSUE 2 0.0004
269 MUCORMYCOSIS 1 0.0004
270 FULL BLOOD COUNT ABNORMAL 4 0.0004
271 FEBRILE NEUTROPENIA 25 0.0004
272 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
273 ANIMAL BITE 1 0.0004
274 RHINITIS 3 0.0004
275 LARGE INTESTINAL ULCER 1 0.0004
276 ACUTE GRAFT VERSUS HOST DISEASE IN SKIN 1 0.0004
277 ANAL HAEMORRHAGE 1 0.0004
278 COLECTOMY 2 0.0004
279 IMMUNE THROMBOCYTOPENIC PURPURA 1 0.0004
280 CEREBRAL THROMBOSIS 1 0.0004
281 LIP PAIN 1 0.0003
282 IMMUNOSUPPRESSION 3 0.0003
283 PROTHROMBIN TIME PROLONGED 2 0.0003
284 MIXED LIVER INJURY 1 0.0003
285 CENTRAL VENOUS CATHETERISATION 1 0.0003
286 BLOOD COUNT ABNORMAL 5 0.0003
287 INTRACARDIAC THROMBUS 1 0.0003
288 BRAIN NATRIURETIC PEPTIDE INCREASED 1 0.0003
289 BLOOD CREATININE DECREASED 1 0.0003
290 ABDOMINAL ADHESIONS 1 0.0003
291 FAECAL CALPROTECTIN INCREASED 1 0.0003
292 ENTERITIS 2 0.0003
293 PANCREATITIS ACUTE 7 0.0003
294 PROCTALGIA 2 0.0003
295 PORTAL VEIN THROMBOSIS 1 0.0003
296 LIVER ABSCESS 1 0.0003
297 BACTERIAL SEPSIS 1 0.0003
298 HYPOVENTILATION 1 0.0003
299 THERAPY CHANGE 3 0.0003
300 ASPERGILLUS INFECTION 2 0.0003
301 OFF LABEL USE 266 0.0003
302 OTITIS MEDIA 1 0.0003
303 VIRAL INFECTION 10 0.0003
304 COAGULOPATHY 5 0.0003
305 NEUTROPHIL COUNT DECREASED 12 0.0003
306 FUNCTIONAL GASTROINTESTINAL DISORDER 1 0.0003
307 HYPERTRANSAMINASAEMIA 2 0.0003
308 ERYTHEMA NODOSUM 1 0.0003
309 JAUNDICE CHOLESTATIC 1 0.0003
310 APPENDICECTOMY 1 0.0003
311 LEUKOPENIA 14 0.0003
312 AMYLASE INCREASED 1 0.0003
313 TRANSAMINASES INCREASED 6 0.0003
314 MATERNAL EXPOSURE TIMING UNSPECIFIED 1 0.0003
315 PROTEIN TOTAL DECREASED 1 0.0003
316 HEPATIC NECROSIS 1 0.0003
317 CHEMOTHERAPY 1 0.0003
318 CATHETER SITE INFECTION 1 0.0003
319 ALANINE AMINOTRANSFERASE INCREASED 16 0.0003
320 DEVICE RELATED INFECTION 4 0.0003
321 BLOOD BILIRUBIN INCREASED 7 0.0003
322 PULMONARY HAEMORRHAGE 2 0.0003
323 DRUG-INDUCED LIVER INJURY 8 0.0003
324 AFFECTIVE DISORDER 2 0.0003
325 RESPIRATORY DISTRESS 7 0.0003
326 BLOOD ALBUMIN DECREASED 2 0.0003
327 HYPERLIPIDAEMIA 3 0.0003
328 SKIN PAPILLOMA 1 0.0002
329 CYSTITIS HAEMORRHAGIC 1 0.0002
330 FUNGAL SKIN INFECTION 1 0.0002
331 ADRENAL INSUFFICIENCY 3 0.0002
332 MATERNAL EXPOSURE DURING BREAST FEEDING 1 0.0002
333 PANCREATITIS 13 0.0002
334 SMALL INTESTINAL OBSTRUCTION 3 0.0002
335 HYPERAESTHESIA 2 0.0002
336 EXPOSURE DURING PREGNANCY 15 0.0002
337 EXPIRED PRODUCT ADMINISTERED 8 0.0002
338 PURULENT DISCHARGE 1 0.0002
339 PSEUDOMONAS INFECTION 2 0.0002
340 CARDIAC OPERATION 2 0.0002
341 HEPATIC LESION 1 0.0002
342 STAPHYLOCOCCAL BACTERAEMIA 1 0.0002
343 NEUROTOXICITY 4 0.0002
344 MELANOCYTIC NAEVUS 1 0.0002
345 CYTOMEGALOVIRUS INFECTION REACTIVATION 1 0.0002
346 ABDOMINAL ABSCESS 1 0.0002
347 ILEUS PARALYTIC 1 0.0002
348 HAEMOLYTIC ANAEMIA 2 0.0002
349 IRON DEFICIENCY 1 0.0002
350 LUPUS-LIKE SYNDROME 2 0.0002
351 HEPATIC ENCEPHALOPATHY 2 0.0002
352 COLITIS MICROSCOPIC 1 0.0002
353 PRE-ECLAMPSIA 1 0.0002
354 ENTEROCOCCAL INFECTION 1 0.0002
355 SEPTIC SHOCK 9 0.0002
356 INFLAMMATORY BOWEL DISEASE 2 0.0002
357 ORGANISING PNEUMONIA 1 0.0002
358 COLITIS ULCERATIVE 9 0.0002
359 PNEUMOCYSTIS JIROVECII PNEUMONIA 2 0.0002
360 TOXIC SKIN ERUPTION 2 0.0002
361 PRODUCT SOLUBILITY ABNORMAL 1 0.0002
362 STOMATITIS 12 0.0002
363 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 1 0.0002
364 AMMONIA INCREASED 1 0.0002
365 CEREBRAL ISCHAEMIA 1 0.0002
366 PETECHIAE 2 0.0002
367 TONSILLITIS 1 0.0002
368 HEPATIC ENZYME INCREASED 13 0.0002
369 SERUM FERRITIN INCREASED 1 0.0002
370 CLOSTRIDIUM DIFFICILE COLITIS 2 0.0002
371 PREMATURE DELIVERY 3 0.0002
372 ANAL FISTULA 1 0.0002
373 GAMMA-GLUTAMYLTRANSFERASE INCREASED 4 0.0002
374 SKIN INFECTION 2 0.0002
375 PRODUCT LEAKAGE 1 0.0002
376 CHOLECYSTITIS ACUTE 1 0.0002
377 EXERCISE TOLERANCE DECREASED 1 0.0002
378 SKIN WARM 1 0.0002
379 BACTERAEMIA 2 0.0002
380 CHOLECYSTITIS 2 0.0002
381 ODYNOPHAGIA 1 0.0002
382 FOETAL GROWTH RESTRICTION 1 0.0002
383 DERMATITIS ACNEIFORM 1 0.0002
384 NEUTROPENIA 22 0.0002
385 PHARYNGITIS 2 0.0002
386 OLIGURIA 1 0.0002
387 HEPATIC STEATOSIS 3 0.0002
388 BACTERIAL INFECTION 3 0.0002
389 INFUSION SITE EXTRAVASATION 1 0.0002
390 IMMUNE SYSTEM DISORDER 2 0.0002
391 PRODUCT FORMULATION ISSUE 1 0.0002
392 EAR INFECTION 4 0.0002
393 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 1 0.0001
394 GINGIVAL BLEEDING 2 0.0001
395 ACUTE HEPATIC FAILURE 2 0.0001
396 EYE MOVEMENT DISORDER 1 0.0001
397 ENCEPHALITIS 1 0.0001
398 MULTIPLE ORGAN DYSFUNCTION SYNDROME 4 0.0001
399 METASTASIS 1 0.0001
400 MYELODYSPLASTIC SYNDROME 2 0.0001
401 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
402 GASTROENTERITIS 2 0.0001
403 ACCIDENTAL OVERDOSE 5 0.0001
404 MOUTH HAEMORRHAGE 1 0.0001
405 THROMBOCYTOPENIA 15 0.0001
406 ASPARTATE AMINOTRANSFERASE INCREASED 7 0.0001
407 SHOCK 3 0.0001
408 DIFFUSE LARGE B-CELL LYMPHOMA 1 0.0001
409 PERICARDIAL EFFUSION 3 0.0001
410 HAEMOLYSIS 1 0.0001
411 APHTHOUS ULCER 1 0.0001
412 LUNG INFECTION 2 0.0001
413 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 1 0.0001
414 ACUTE MYELOID LEUKAEMIA 2 0.0001
415 GASTROINTESTINAL INFLAMMATION 1 0.0001
416 FURUNCLE 1 0.0001
417 NASAL DISCOMFORT 1 0.0001
418 UTERINE CANCER 1 0.0001
419 FOETAL EXPOSURE DURING PREGNANCY 10 0.0001
420 ESCHERICHIA INFECTION 1 0.0001
421 PYREXIA 42 0.0001
422 PHOTOSENSITIVITY REACTION 2 0.0001
423 GENERALISED TONIC-CLONIC SEIZURE 2 0.0001
424 SECOND PRIMARY MALIGNANCY 1 0.0001
425 FUNGAL INFECTION 4 0.0001
426 CANDIDA INFECTION 2 0.0001
427 MYOPATHY 1 0.0001
428 LYMPHOCYTE COUNT DECREASED 2 0.0001
429 CARDIOTOXICITY 1 0.0001
430 ABDOMINAL PAIN 26 0.0001
431 THERAPEUTIC PRODUCT EFFECT DECREASED 5 0.0001
432 ANAL INCONTINENCE 1 0.0001
433 MYELOSUPPRESSION 4 0.0001
434 ANAPHYLACTIC REACTION 6 0.0001
435 IRON DEFICIENCY ANAEMIA 1 0.0001
436 AGRANULOCYTOSIS 2 0.0001
437 MIDDLE INSOMNIA 2 0.0001
438 LACERATION 1 0.0001
439 SQUAMOUS CELL CARCINOMA 1 0.0001
440 SPINAL DISORDER 1 0.0001
441 COLITIS 4 0.0001
442 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 1 0.0001
443 SEIZURE 12 0.0001
444 HYPERCHOLESTEROLAEMIA 1 0.0001
445 DRUG INTOLERANCE 10 0.0001
446 ORAL HERPES 2 0.0001
447 ASCITES 3 0.0001
448 LIGAMENT SPRAIN 1 0.0001
449 HAEMATOCRIT DECREASED 2 0.0001
450 ADVERSE DRUG REACTION 9 0.0001
451 CYTOKINE RELEASE SYNDROME 2 0.0001
452 PREMATURE BABY 3 0.0001
453 FULL BLOOD COUNT DECREASED 2 0.0001
454 PERITONITIS BACTERIAL 1 0.0001
455 PRODUCT ADMINISTRATION ERROR 2 0.0001
456 HYPOTHERMIA 1 0.0001
457 SEPSIS 11 0.0001
458 SLUGGISHNESS 1 0.0001
459 PERITONITIS 2 0.0001
460 PRODUCT ODOUR ABNORMAL 1 0.0001
461 FOLLICULITIS 1 0.0001
462 MOUTH ULCERATION 2 0.0001
463 SCRATCH 1 0.0001
464 RECTAL HAEMORRHAGE 4 0.0001
465 NIGHT SWEATS 3 0.0001
466 POOR QUALITY SLEEP 2 0.0001
467 CHOLELITHIASIS 3 0.0001
468 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
469 MALNUTRITION 1 0.0001
470 NEPHROPATHY TOXIC 1 0.0001
471 CHROMATURIA 2 0.0001
472 MYOCARDITIS 1 0.0001
473 METASTASES TO LUNG 1 0.0001
474 SPLENOMEGALY 1 0.0001
475 VOMITING 40 0.0001
476 LYMPHADENOPATHY 3 0.0001
477 COVID-19 PNEUMONIA 1 0.0001
478 PRODUCT PRESCRIBING ERROR 2 0.0001
479 POLYNEUROPATHY 1 0.0001
480 SKIN EXFOLIATION 7 0.0001
481 NOCTURIA 1 0.0001
482 NEURALGIA 2 0.0001
483 CYTOPENIA 1 0.0001
484 LIVER INJURY 2 0.0001
485 ENCEPHALOPATHY 2 0.0001
486 BLOOD ALKALINE PHOSPHATASE INCREASED 2 0.0001
487 HEPATIC FUNCTION ABNORMAL 3 0.0001
488 EPISTAXIS 6 0.0001
489 HAEMATEMESIS 2 0.0001
490 HEPATIC CYTOLYSIS 1 0.0001
491 HEPATITIS 2 0.0001
492 THERAPY CESSATION 4 0.0001
493 HAEMOGLOBIN DECREASED 8 0.0001
494 DRUG RESISTANCE 2 0.0001
495 RESPIRATORY TRACT INFECTION 2 0.0001
496 INFECTION 11 0.0001
497 FREQUENT BOWEL MOVEMENTS 2 0.0001
498 WHITE BLOOD CELL COUNT DECREASED 8 0.0001
499 TACHYPNOEA 1 0.0001
500 TREATMENT FAILURE 6 0.0001
501 ORAL DISCOMFORT 1 0.0001
502 BLOOD TEST ABNORMAL 1 0.0001
503 IMPAIRED QUALITY OF LIFE 1 0.0001
504 LIVER FUNCTION TEST ABNORMAL 2 0.0001
505 LIVER DISORDER 3 0.0001
506 DRUG EFFECT LESS THAN EXPECTED 1 0.0001
507 IMMUNODEFICIENCY 1 0.0001
508 GASTROINTESTINAL DISORDER 6 0.0001
509 THERAPY NON-RESPONDER 3 0.0001
510 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
511 DRUG ADMINISTRATION ERROR 2 0.0001
512 UPPER RESPIRATORY TRACT INFECTION 3 0.0001
513 MUSCULOSKELETAL CHEST PAIN 1 0.0001
514 THERAPY PARTIAL RESPONDER 1 0.0001
515 BASAL CELL CARCINOMA 1 0.0001
516 ANAEMIA 12 0.0001
517 ULCER 1 0.0001
518 METABOLIC ACIDOSIS 2 0.0001
519 CARDIAC FAILURE 5 0.0001
520 BACK DISORDER 1 0.0001
521 IMPAIRED HEALING 2 0.0001
522 OSTEONECROSIS 2 0.0001
523 STAPHYLOCOCCAL INFECTION 2 0.0001
524 DRUG LEVEL INCREASED 1 0.0001
525 PERICARDITIS 1 0.0001
526 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 1 0.0001
527 PRODUCT STORAGE ERROR 5 0.0001
528 EOSINOPHILIA 1 0.0001
529 HYPERKALAEMIA 2 0.0001
530 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
531 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
532 PLATELET COUNT DECREASED 6 0.0001
533 ISCHAEMIC STROKE 1 0.0001
534 CEREBRAL HAEMORRHAGE 2 0.0001
535 PELVIC PAIN 1 0.0001
536 RESPIRATORY FAILURE 4 0.0001
537 CONJUNCTIVITIS 1 0.0001
538 TUBULOINTERSTITIAL NEPHRITIS 1 0.0001
539 BLOOD SODIUM DECREASED 1 0.0001
540 MUSCULOSKELETAL DISORDER 1 0.0001
541 PULMONARY FIBROSIS 1 0.0001
542 POST PROCEDURAL COMPLICATION 1 0.0001
543 HOSPITALISATION 8 0.0001
544 DECREASED APPETITE 12 0.0001
545 SKIN FISSURES 1 0.0001
546 ABORTION SPONTANEOUS 2 0.0000
547 FEEDING DISORDER 1 0.0000
548 BODY TEMPERATURE INCREASED 1 0.0000
549 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
550 DERMATITIS 1 0.0000
551 IMPAIRED WORK ABILITY 1 0.0000
552 LIVER FUNCTION TEST INCREASED 1 0.0000
553 SKIN CANCER 1 0.0000
554 PRURITUS GENERALISED 1 0.0000
555 PRODUCT DISPENSING ERROR 1 0.0000
556 MELAENA 1 0.0000
557 ANGIOEDEMA 2 0.0000
558 STEVENS-JOHNSON SYNDROME 1 0.0000
559 RASH PAPULAR 1 0.0000
560 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
561 PRODUCT AVAILABILITY ISSUE 1 0.0000
562 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 1 0.0000
563 DISEASE RECURRENCE 2 0.0000
564 THERAPY INTERRUPTED 3 0.0000
565 RASH ERYTHEMATOUS 2 0.0000
566 LUNG DISORDER 2 0.0000
567 PNEUMONIA 13 0.0000
568 PNEUMONIA ASPIRATION 1 0.0000
569 ACUTE KIDNEY INJURY 6 0.0000
570 RASH 17 0.0000
571 ANAPHYLACTIC SHOCK 1 0.0000
572 RASH GENERALISED 1 0.0000
573 DIPLOPIA 1 0.0000
574 NAUSEA 30 0.0000
575 DRUG INTERACTION 6 0.0000
576 HYPERSENSITIVITY 7 0.0000
577 BRADYCARDIA 2 0.0000
578 JAUNDICE 1 0.0000
579 OVERDOSE 8 0.0000
580 PALLOR 1 0.0000
581 PNEUMONITIS 1 0.0000
582 SKIN LESION 1 0.0000
583 PRODUCT USE IN UNAPPROVED INDICATION 9 0.0000
584 MEDICATION ERROR 2 0.0000
585 INFLUENZA 4 0.0000
586 ALOPECIA 7 0.0000
587 BLISTER 2 0.0000
588 RED BLOOD CELL COUNT DECREASED 1 0.0000
589 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
590 TACHYCARDIA 3 0.0000
591 RESPIRATORY DISORDER 1 0.0000
592 HEPATIC FAILURE 1 0.0000
593 PLEURAL EFFUSION 2 0.0000
594 VERTIGO 2 0.0000
595 BONE DENSITY DECREASED 1 0.0000
596 NEUROPATHY PERIPHERAL 3 0.0000
597 HIP FRACTURE 1 0.0000
598 LACTIC ACIDOSIS 1 0.0000
599 SKIN DISORDER 1 0.0000
600 TYPE 2 DIABETES MELLITUS 1 0.0000
601 SINUSITIS 3 0.0000
602 GASTRIC DISORDER 1 0.0000
603 COVID-19 5 0.0000
604 HYPOXIA 1 0.0000
605 DYSURIA 1 0.0000
606 BRONCHITIS 2 0.0000
607 EYE SWELLING 1 0.0000
608 DYSPNOEA EXERTIONAL 1 0.0000
609 DIARRHOEA 17 0.0000
610 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
611 CHILLS 3 0.0000
612 DISEASE PROGRESSION 3 0.0000
613 THROMBOSIS 2 0.0000
614 GASTROOESOPHAGEAL REFLUX DISEASE 2 0.0000
615 DYSKINESIA 1 0.0000
616 ABDOMINAL PAIN UPPER 5 0.0000
617 ABDOMINAL DISCOMFORT 4 0.0000
618 URINARY TRACT INFECTION 4 0.0000
619 RENAL FAILURE 3 0.0000
620 MATERNAL EXPOSURE DURING PREGNANCY 2 0.0000
621 THROAT IRRITATION 1 0.0000
622 NEPHROLITHIASIS 1 0.0000
623 TINNITUS 1 0.0000
624 OROPHARYNGEAL PAIN 2 0.0000
625 PRODUCT USE ISSUE 4 0.0000
626 DYSPHAGIA 2 0.0000
627 PULMONARY EMBOLISM 2 0.0000
628 BLOOD GLUCOSE DECREASED 1 0.0000
629 CONTUSION 2 0.0000
630 INTERSTITIAL LUNG DISEASE 1 0.0000
631 SYNCOPE 2 0.0000
632 CONDITION AGGRAVATED 6 0.0000
633 ERYTHEMA 4 0.0000
634 ILLNESS 2 0.0000
635 INFLAMMATION 1 0.0000
636 HEADACHE 12 0.0000
637 ECZEMA 1 0.0000
638 DEPRESSED MOOD 1 0.0000
639 OEDEMA 1 0.0000
640 TREATMENT NONCOMPLIANCE 1 0.0000
641 HAEMATOCHEZIA 1 0.0000
642 ARTHROPATHY 1 0.0000
643 URTICARIA 3 0.0000
644 COUGH 5 0.0000
645 TOXICITY TO VARIOUS AGENTS 3 0.0000
646 FLATULENCE 1 0.0000
647 MUSCULAR WEAKNESS 2 0.0000
648 PRODUCT SUBSTITUTION ISSUE 1 0.0000
649 DYSPHONIA 1 0.0000
650 IRRITABILITY 1 0.0000
651 THERAPEUTIC RESPONSE DECREASED 1 0.0000
652 PRURITUS 6 0.0000
653 FATIGUE 12 0.0000
654 DEEP VEIN THROMBOSIS 1 0.0000
655 SWELLING FACE 1 0.0000
656 PRODUCT DOSE OMISSION 1 0.0000
657 PSORIASIS 2 0.0000
658 INFUSION RELATED REACTION 1 0.0000
659 BLOOD PRESSURE DECREASED 1 0.0000
660 DEHYDRATION 2 0.0000
661 NEOPLASM MALIGNANT 1 0.0000
662 HYPOTENSION 3 0.0000
663 ARTHRALGIA 6 0.0000
664 WEIGHT DECREASED 4 0.0000
665 SLEEP DISORDER 1 0.0000
666 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
667 UNDERDOSE 1 0.0000
668 PAIN IN EXTREMITY 4 0.0000
669 UNEVALUABLE EVENT 1 0.0000
670 ACNE 1 0.0000
671 DIABETES MELLITUS 1 0.0000
672 PARAESTHESIA 2 0.0000
673 INFLUENZA LIKE ILLNESS 1 0.0000
674 CARDIAC ARREST 1 0.0000
675 DRUG DOSE OMISSION 2 0.0000
676 TREMOR 2 0.0000
677 MYALGIA 2 0.0000
678 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
679 MALAISE 5 0.0000
680 DRUG INEFFECTIVE 15 0.0000
681 MUSCLE SPASMS 2 0.0000
682 NASOPHARYNGITIS 2 0.0000
683 CHEST PAIN 2 0.0000
684 ASTHENIA 4 0.0000
685 BLOOD GLUCOSE INCREASED 2 0.0000
686 ATRIAL FIBRILLATION 1 0.0000
687 HEART RATE INCREASED 1 0.0000
688 CHEST DISCOMFORT 1 0.0000
689 MALIGNANT NEOPLASM PROGRESSION 1 0.0000
690 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
691 ABDOMINAL DISTENSION 1 0.0000
692 CONSTIPATION 2 0.0000
693 ASTHMA 1 0.0000
694 PALPITATIONS 1 0.0000
695 OEDEMA PERIPHERAL 1 0.0000
696 VISUAL IMPAIRMENT 1 0.0000
697 ANXIETY 2 0.0000
698 BLOOD PRESSURE INCREASED 1 0.0000
699 PERIPHERAL SWELLING 1 0.0000
700 FALL 2 0.0000
701 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 1 0.0000
702 NO ADVERSE EVENT 1 0.0000
703 DYSPNOEA 3 0.0000
704 GAIT DISTURBANCE 1 0.0000
705 SOMNOLENCE 1 0.0000
706 INCORRECT DOSE ADMINISTERED 1 0.0000
707 BACK PAIN 1 0.0000
708 INSOMNIA 1 0.0000
709 PRODUCT DOSE OMISSION ISSUE 1 0.0000
710 PAIN 2 0.0000
711 DIZZINESS 1 0.0000
712 DEATH 1 0.0000